跳轉至內容
Merck
  • Pyruvate protects against experimental stroke via an anti-inflammatory mechanism.

Pyruvate protects against experimental stroke via an anti-inflammatory mechanism.

Neurobiology of disease (2009-07-29)
Qing Wang, Michael van Hoecke, Xian Nan Tang, Hokyou Lee, Zheng Zheng, Raymond A Swanson, Midori A Yenari
摘要

Pyruvate, a key intermediate in glucose metabolism, was explored as a potential treatment in models of experimental stroke and inflammation. Pyruvate was administered to rodents after the onset of middle cerebral artery occlusion (MCAO). Since the extent of inflammation is often proportional to the size of the infarct, we also studied a group of animals given lipopolysaccharide (LPS) to cause brain inflammation without cell death. Following MCAO, pyruvate did not affect physiological parameters but significantly reduced infarct volume, improved behavioral tests and reduced numbers of neutrophils, microglial and NFkappaB activation. Animals given LPS showed increased microglial and NFkappaB activation which was almost completely abolished by pyruvate. Lactate, a major metabolite of pyruvate, was increased after pyruvate administration. However, administration of lactate itself did not have any anti-inflammatory effects. Pyruvate protects against ischemia possibly by blocking inflammation, but lactate itself does not appear to explain pyruvate's anti-inflammatory properties.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
来自西非单叶豆加纳籽)的凝集素, Isolectin B4 (BSI-B4), peroxidase conjugate, lyophilized powder